FDA Probing Abbott Device's Higher Rate Of Cardiac Events
The U.S. Food and Drug Administration recently told health care providers that there's an increased rate of major cardiac events seen in patients treated with an Abbott Inc. medical device implanted...To view the full article, register now.
Already a subscriber? Click here to view full article